rs376462712
Variant names:
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_020247.5(COQ8A):c.697G>A(p.Ala233Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000503 in 1,567,260 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00027 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00053 ( 12 hom. )
Consequence
COQ8A
NM_020247.5 missense
NM_020247.5 missense
Scores
1
5
11
Clinical Significance
Conservation
PhyloP100: 7.19
Publications
1 publications found
Genes affected
COQ8A (HGNC:16812): (coenzyme Q8A) This gene encodes a mitochondrial protein similar to yeast ABC1, which functions in an electron-transferring membrane protein complex in the respiratory chain. It is not related to the family of ABC transporter proteins. Expression of this gene is induced by the tumor suppressor p53 and in response to DNA damage, and inhibiting its expression partially suppresses p53-induced apoptosis. Alternatively spliced transcript variants have been found; however, their full-length nature has not been determined. [provided by RefSeq, Jul 2008]
COQ8A Gene-Disease associations (from GenCC):
- autosomal recessive ataxia due to ubiquinone deficiencyInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- coenzyme Q10 deficiencyInheritance: AR Classification: DEFINITIVE Submitted by: Illumina
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.009729356).
BP6
Variant 1-226977490-G-A is Benign according to our data. Variant chr1-226977490-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 214033.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000269 (41/152288) while in subpopulation SAS AF = 0.00849 (41/4828). AF 95% confidence interval is 0.00643. There are 0 homozygotes in GnomAd4. There are 31 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 12 AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COQ8A | ENST00000366777.4 | c.697G>A | p.Ala233Thr | missense_variant | Exon 5 of 15 | 1 | NM_020247.5 | ENSP00000355739.3 | ||
ENSG00000288674 | ENST00000366779.6 | n.*5424G>A | non_coding_transcript_exon_variant | Exon 22 of 32 | 2 | ENSP00000355741.2 | ||||
ENSG00000288674 | ENST00000366779.6 | n.*5424G>A | 3_prime_UTR_variant | Exon 22 of 32 | 2 | ENSP00000355741.2 |
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 41AN: 152170Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
41
AN:
152170
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00134 AC: 232AN: 173048 AF XY: 0.00176 show subpopulations
GnomAD2 exomes
AF:
AC:
232
AN:
173048
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000529 AC: 748AN: 1414972Hom.: 12 Cov.: 31 AF XY: 0.000761 AC XY: 532AN XY: 699320 show subpopulations
GnomAD4 exome
AF:
AC:
748
AN:
1414972
Hom.:
Cov.:
31
AF XY:
AC XY:
532
AN XY:
699320
show subpopulations
African (AFR)
AF:
AC:
0
AN:
32878
American (AMR)
AF:
AC:
0
AN:
36968
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25238
East Asian (EAS)
AF:
AC:
0
AN:
37946
South Asian (SAS)
AF:
AC:
669
AN:
80378
European-Finnish (FIN)
AF:
AC:
1
AN:
49102
Middle Eastern (MID)
AF:
AC:
1
AN:
5618
European-Non Finnish (NFE)
AF:
AC:
49
AN:
1088170
Other (OTH)
AF:
AC:
28
AN:
58674
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
43
86
128
171
214
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.000269 AC: 41AN: 152288Hom.: 0 Cov.: 33 AF XY: 0.000416 AC XY: 31AN XY: 74452 show subpopulations
GnomAD4 genome
AF:
AC:
41
AN:
152288
Hom.:
Cov.:
33
AF XY:
AC XY:
31
AN XY:
74452
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41562
American (AMR)
AF:
AC:
0
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5158
South Asian (SAS)
AF:
AC:
41
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
0
AN:
68010
Other (OTH)
AF:
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
126
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Benign:4
Sep 02, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
COQ8A: BS2 -
Apr 12, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Mar 16, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Autosomal recessive cerebellar ataxia Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;T
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
.;D;D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Uncertain
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
P;.;P
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.